Close Menu

USAMRIID

NEW YORK (GenomeWeb) – An American team led by researchers at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) has come up with a proposed set of standards for investigators sequencing and assembling viral genomes.

ZyGem said today that it has signed a cooperative research and development agreement with the US Army Medical Research Institute of Infectious Diseases to develop simplified sample processing tools for biothreat agent detection.

Biomatrica and USAMRIID will collaborate to develop, test, validate, and eventually commercialize new formulations designed to stabilize clinical samples and biological agents at ambient conditions.

The company also released its 2010 financial results, posting a jump in its net loss despite increased revenues.

The agreement provides Akonni access to nucleic acid sequences, primers, and probes for several important biothreat agents, which it will incorporate into molecular tests on its TruArray and TruSentry platforms.

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.